Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

16.2.17

Acute Exacerbation of COPD

Malawi Standard Treatment Guidelines, 6th Edition, 2023. Chapter 16, Respiratory Conditions.

Clinical Description

Acute worsening of dyspnoea, increased sputum volume, purulent sputum (+ / -fever) that requires additional treatment

  • Exacerbations progression and result in loss of lung function and poor quality of life
  • can be mild, moderate, or severe

Causes of exacerbations

  • tracheobronchial infections main trigger - viral (rhinovirus) > bacterial (S.

pneumoniae, H. influenzae, Moraxella catarrhalis. Consider Pseudomonas aeruginosa if frequent exacerbator and recent hospital admission)

  • environmental exposure / air pollution (respirable particles, ozone)
  • allergens
  • aspiration and GORD
  • weather changes
  • discontinuation of maintenance treatment

Differential diagnosis of exacerbations

  • non-pulmonary infections
  • pulmonary embolism
  • pneumothorax
  • pleural effusion
  • CCF with pulmonary oedema

Investigations

  • FBC, blood culture, sputum analysis, CXR

Treatment

  • Exacerbations need bronchodilators, antibiotics, and steroids
  • Nebulized salbutamol 5mg / ipratroprium bromide and oral aminophylline 100 mg 8 hourly PO. Can use salbutamol inhaler with spacer if no nebulised salbutamol
  • Prednisolone 40 mg daily PO for 5 days (5 days course is enough).

Steroids shorten hospital stay / recovery time and improve lung function oxygenation and clinical outcome.

  • Antibiotics (if bacterial infection trigger suspected)
  • Amoxicillin 1g 8 hourly PO for 7 days. Alternative Amoxicillin + Clavulanic acid (AugmentinR) 625mg 8 hourly PO or doxycycline 100mg 12 hourly or azithromycin 500mg daily.

ceftriaxone 2g daily IV (if severe exacerbation) o if frequent exacerbation with recent hospital admission and antibiotic use: cover for Pseudomonas spp e.g., with ciprofloxacin 500mg 12 hourly for 7 days

  • oxygen saturation and the use of oxygen
  • COPD patients often have lower SpO2 than asthma patients, even when stable.

o in asthma, if SpO2 drops below 95%, it is worrisome.

o a COPD patient may be stable with SpO2 as low as 87%.

  • avoid the use of high flow oxygen in COPD patients wherever possible (as oxygen may remove their hypoxia dependent respiratory drive and cause hypoventilation→ CO2 retention, narcosis → coma).
  • use 2 L / min oxygen as treatment or less, or to target SpO2 to 88 - 92 %.

NIV (non-invasive ventilation) for severe exacerbation: CPAP is preferred if no contraindications

  • Improves oxygenation / gas exchange / survival
  • Reduce work of breathing and need for intubation
  • Reduce hospital stay
  • Improves respiratory acidosis

Before discharge

  • start inhaled bronchodilators asap when stable before hospital discharge
  • if frequent exacerbator: regular salbutal 2 puffs 6hrly through spacer
  • long term use of oral steroid is not required
  • plan for follow-up within 1 month: 20% of patients may not recover at 8 weeks

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.